◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksFORM › EBITDA

FormFactor Inc (FORM) EBITDA 2006–TTM

DATA UPDATED 2026-08-09

FormFactor Inc annual ebitda for fiscal TTM was $171 million, an increase of 48.7% from $115 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

FORM Annual EBITDA

EBITDA (annual)TTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
EBITDA$171M$115M$113M$83M$96M$144M$135M$98M$81M$91M($1M)$20M$14M($24M)($47M)($58M)($97M)($102M)($92M)$120M$95M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

FORM Quarterly EBITDA

EBITDA (quarterly)2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
EBITDA$68M$30M$40M$33M$23M$18M$52M$29M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EBITDA at Comparable Companies

More FORM metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow · Shares Outstanding

All FORM financial statements → Interactive FORM charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.